XML 29 R71.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Tax Contingency [Line Items]      
Domestic $ 25,794,000 $ 16,177,000 $ 9,551,000
Foreign 1,281,000 (88,000) 406,000
Income before provision for income taxes 27,075,000 16,089,000 9,957,000
Current:      
Federal 7,181,000 4,285,000 196,000
State 1,006,000 896,000 207,000
Foreign 154,000 (70,000) 368,000
Total current 8,341,000 5,111,000 771,000
Deferred:      
Federal 2,169,000 1,116,000 3,757,000
State 651,000 (527,000) 473,000
Foreign (264,000) 0 64,000
Total deferred 2,556,000 589,000 4,294,000
Provision for income taxes 10,897,000 5,700,000 5,065,000
Income Tax Reconciliation:      
U.S. federal tax provision at statutory rate 9,476,000 5,631,000 3,485,000
State taxes 1,077,000 240,000 543,000
Non-deductible expenses 530,000 481,000 350,000
Acquisition costs 431,000 0 0
Share-based compensation expense 403,000 443,000 244,000
Research tax credits 0 (755,000) (137,000)
Repatriation of foreign earnings 0 (77,000) 560,000
Domestic production deduction (601,000) (271,000) 0
Other (419,000) 8,000 20,000
Provision for income taxes 10,897,000 5,700,000 5,065,000
Components of Deferred Tax Assets and Liabilities:      
Deferred Tax Assets, Tax Credit Carryforwards 2,990,000 3,066,000  
Deferred Tax Assets, Inventory related items 2,900,000 3,032,000  
Deferred Tax Assets, Deferred revenue 11,497,000 11,979,000  
Deferred Tax Assets, Stock compensation 9,331,000 9,187,000  
Deferred Tax Assets, Loss carry forwards 53,000 0  
Deferred Tax Assets, Other net 69,000 82,000  
Deferred Tax Assets, Gross 26,840,000 27,346,000  
Deferred Tax Assets, Valuation Allowance (39,000) 0  
Deferred Tax Assets, Net of Valuation Allowance 26,801,000 27,346,000  
Deferred Tax Liabilities, Reserves and accruals (573,000) (1,277,000)  
Deferred Tax Liabilities, Depreciation and amortization (39,840,000) (4,040,000)  
Deferred Tax Liabilities, Gross (40,413,000) (5,317,000)  
Deferred Tax Assets, Net   22,029,000  
Deferred Tax Liabilities, Net 13,612,000    
Reconciliation of Unrecognized Tax Benefits [Roll Forward]      
Unrecognized Tax Benefits 5,796,000 5,431,000 4,295,000
Increases related to tax positions taken during a prior period 43,000 0 795,000
Increases related to tax positions related to MTS 1,066,000    
Decreases related to tax positions taken during the prior period 0 (88,000) (80,000)
Increases related to tax positions taken during the current period 422,000 453,000 421,000
Decreases related to settlements (33,000)    
Decreases related to expiration of statute of limitations (379,000)    
Unrecognized Tax Benefits 6,915,000 5,796,000 5,431,000
Tax effected amounts of gross unrealized net operating loss and business tax credit carry forwards excluded under ASC 718 3,200,000    
Undistributed Earnings of Foreign Subsidiaries 2,200,000    
Unrecognized tax benefits that would affect tax expense 6,100,000    
State and Local Jurisdiction [Member]
     
Reconciliation of Unrecognized Tax Benefits [Roll Forward]      
Operating Loss Carryforwards 1,500,000    
State and Local Jurisdiction [Member] | Research Tax Credit Carryforward [Member]
     
Reconciliation of Unrecognized Tax Benefits [Roll Forward]      
Tax Credit Carryforward, Amount 6,700,000    
Internal Revenue Service (IRS) [Member] | Research Tax Credit Carryforward [Member]
     
Reconciliation of Unrecognized Tax Benefits [Roll Forward]      
Tax Credit Carryforward, Amount 3,000,000    
MTS-Medication Technologies [Member]
     
Components of Deferred Tax Assets and Liabilities:      
Deferred Tax Liabilities, Net $ 33,100,000